Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis

Published:2006-08 Issue:8 Volume:24 Page:1663-1670
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Gao Xiao-Ming,Wong Geoffrey,Wang Binghui,Kiriazis Helen,Moore Xiao-Lei,Su Yi-Dan,Dart Anthony,Du Xiao-Jun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference37 articles.

1. Prognostic implications of left ventricular hypertrophy;Vakili;Am Heart J,2001

2. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events;Okin;JAMA,2004

3. Cardiac hypertrophy: the good, the bad, and the ugly;Frey;Annu Rev Physiol,2003

4. TOR, a central controller of cell growth;Schmelzle;Cell,2000

5. The TOR pathway: a target for cancer therapy;Bjornsti;Nat Rev Cancer,2004

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Basis of Hypertrophic Cardiomyopathy in Cats;Current Issues in Molecular Biology;2024-08-12

2. Progenitor Cell Function and Cardiovascular Remodelling Induced by SGLT2 Inhibitors;Frontiers in Bioscience-Landmark;2024-04-09

3. Multi-Omic, Histopathologic, and Clinicopathologic Effects of Once-Weekly Oral Rapamycin in a Naturally Occurring Feline Model of Hypertrophic Cardiomyopathy: A Pilot Study;Animals;2023-10-12

4. Autophagy in Heart Failure: Insights into Mechanisms and Therapeutic Implications;Journal of Cardiovascular Development and Disease;2023-08-18

5. Delayed-release rapamycin halts progression of left ventricular hypertrophy in subclinical feline hypertrophic cardiomyopathy: results of the RAPACAT trial;Journal of the American Veterinary Medical Association;2023-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3